These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 15539265)

  • 41. Models for describing absorption rate and estimating extent of bioavailability: application to cefetamet pivoxil.
    Holford NH; Ambros RJ; Stoeckel K
    J Pharmacokinet Biopharm; 1992 Oct; 20(5):421-42. PubMed ID: 1287195
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Influence of maturation and growth on cefetamet pivoxil pharmacokinetics: rational dosing for infants.
    Hayton WL; Kneer J; de Groot R; Stoeckel K
    Antimicrob Agents Chemother; 1996 Mar; 40(3):567-74. PubMed ID: 8851572
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cefetamet pivoxil in paediatric patients suffering from lower respiratory tract infections.
    Gatzola-Karaveli M; Vogiatzis N; Rousso I; Sklavuno-Tsurutsoglu S; Germano G; Kissling M
    Pharmatherapeutica; 1989; 5(6):423-8. PubMed ID: 2687898
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of cefetamet-pivoxil on intestinal microflora: in vivo study.
    Gismondo MR; Drago L; Lombardi A; Fassina C
    J Chemother; 1994 Aug; 6(4):246-50. PubMed ID: 7830102
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical Features of Carnitine Deficiency Secondary to Pivalate-Conjugated Antibiotic Therapy.
    Kobayashi H; Fukuda S; Yamada K; Hasegawa Y; Takahashi T; Purevsuren J; Yamaguchi S
    J Pediatr; 2016 Jun; 173():183-7. PubMed ID: 27059912
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Identification of pivaloylcarnitine in urine of patients with pivoxil therapy].
    Kusunoki Y; Osana K; Yoshioka H
    No To Hattatsu; 1992 Sep; 24(5):494-6. PubMed ID: 1389335
    [No Abstract]   [Full Text] [Related]  

  • 47. Interaction between pivaloylcarnitine and L-carnitine transport into L6 cells overexpressing hOCTN2.
    Todesco L; Bodmer M; Vonwil K; Häussinger D; Krähenbühl S
    Chem Biol Interact; 2009 Aug; 180(3):472-7. PubMed ID: 19539806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Carnitine import to isolated hepatocytes and synthesis are accelerated in pivalate-treated rats.
    Nakajima H; Inoue F; Kizaki Z; Terada N; Okochi M; Kinugasa A; Sawada T
    J Nutr; 1999 Sep; 129(9):1688-91. PubMed ID: 10460205
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Carnitine content of red blood cells of human subjects treated with pivampicillin and carnitine.
    Melegh B; Jászai V
    Acta Paediatr Hung; 1991; 31(2):255-61. PubMed ID: 1867892
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Carnitine supplementation ameliorates the steatosis and ketosis induced by pivalate in rats.
    Bianchi PB; Lehotay DC; Davis AT
    J Nutr; 1996 Nov; 126(11):2873-9. PubMed ID: 8914960
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cefetamet pivoxil: comparable evaluation with other orally available antibiotics against selected species of respiratory pathogens.
    Speciale A; Caccamo F; Blandino G; Giacchi GT; Aleo G; Nicoletti G
    Chemotherapy; 1996; 42(1):1-10. PubMed ID: 8751262
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Carnitine-related hypoglycemia caused by 3 days of pivalate antibiotic therapy in a patient with severe muscular dystrophy: a case report.
    Ito M; Fukuda M; Suzuki Y; Wakamoto H; Ishii E
    BMC Pediatr; 2017 Mar; 17(1):73. PubMed ID: 28292283
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Research on the Clinical Practical Use of Pivoxil-Conjugated Antibodies and the Risk of Carnitine Deficiency Using Real-World Data.
    Suzuki-Yoshida K; Nakano K; Nakakuni M; Deguchi N; Mitsui S; Kobayashi S; Yamatani A; Akabane M
    Children (Basel); 2024 Jan; 11(2):. PubMed ID: 38397263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sodium pivalate treatment reduces tissue carnitines and enhances ketosis in rats.
    Bianchi PB; Davis AT
    J Nutr; 1991 Dec; 121(12):2029-36. PubMed ID: 1941267
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pivampicillin-promoted excretion of pivaloylcarnitine in humans.
    Melegh B; Kerner J; Bieber LL
    Biochem Pharmacol; 1987 Oct; 36(20):3405-9. PubMed ID: 3675603
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Esters of cephalosporins part IX. New method of isolation of cefetamet pivoxil.
    Oszczapowicz I; Teodorczyk A; Tejchman B
    Acta Pol Pharm; 2004; 61(5):321-5. PubMed ID: 15747687
    [TBL] [Abstract][Full Text] [Related]  

  • 57. beta-Hydroxybutyrate oxidation is reduced and hepatic balance of ketone bodies and free fatty acids is unaltered in carnitine-depleted, pivalate-treated rats.
    Bianchi PB; Davis AT
    J Nutr; 1996 Nov; 126(11):2867-72. PubMed ID: 8914959
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Pivalate lowers litter sizes and weights in female rats independent of its effect on carnitine status.
    Doberenz J; Hirche F; Keller U; Eder K
    Reprod Toxicol; 2007 Jul; 24(1):83-8. PubMed ID: 17482425
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical trials on pediatric lower-respiratory-tract infection: results and comments with cefetamet pivoxil.
    Paupe J; Sarbeji M; Scheinmann P; Delacourt C; Sorin M
    Chemotherapy; 1992; 38 Suppl 2():29-32. PubMed ID: 1516462
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Efficacy and tolerability of cefetamet pivoxil in diabetic patients with urinary tract infections: a case-control study.
    Sourander L; Kissling M
    Curr Med Res Opin; 1991; 12(5):304-8. PubMed ID: 2004543
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.